Auxora Revenue and Competitors

Duarte, CA USA

Location

N/A

Total Funding

Telecom

Industry

Estimated Revenue & Valuation

  • Auxora's estimated annual revenue is currently $5.5M per year.(i)
  • Auxora's estimated revenue per employee is $227,500

Employee Data

  • Auxora has 24 Employees.(i)
  • Auxora grew their employee count by 0% last year.

Auxora's People

NameTitleEmail/Phone
1
VP Sales & Business DevReveal Email/Phone
2
Sr. Sales Engineering ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$78.3M219-9%N/AN/A
#2
$142.2M350N/AN/AN/A
#3
$16.7M57-15%N/AN/A
#4
$3.5M180%N/AN/A
#5
$29.9M9210%$17MN/A
#6
$2970M1927%$700MN/A
#7
$0.2M6-25%$29.7MN/A
#8
$8.3M32-3%N/AN/A
#9
$2.7M140%N/AN/A
#10
$52.6M14710%N/AN/A
Add Company

What Is Auxora?

We at Auxora are very proud to have assembled an outstanding technical team that consists of experts in optical engineering, thin film design, vacuum deposition, material sciences, optical fabrication, fiber optic measurement, and software and automation. This wealth of talent enables us to develop deposition technologies that produce thin films with consistent and predictable properties and with thickness controls precise to the molecular level.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$5.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Auxora News

2022-04-13 - CalciMedica Announces Publication of Results from CARDEA ...

Results further support therapeutic potential of Auxora in respiratory diseases and other inflammatory diseases. LA JOLLA, Calif., April 14,...

2022-04-06 - Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial

Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M28-12%N/A
#2
$6.1M317%N/A
#3
$5.8M32-3%N/A
#4
$4M504%N/A
#5
$11M540%N/A